About Yonghua Capital
Yonghua Capital is a private equity firm founded in 1994. It is primarily based in Shanghai, China. In the last 12 months, it has participated in 5 funding rounds.
Overall Yonghua Capital portfolio has seen 3 unicorns, 20 IPOs and 5 acquisitions including key companies like Leapmotor, Cambricon and Mesa Labs. A lot of funds co-invest with Yonghua Capital, with names like Sequoia Capital sharing a substantial percentage of its portfolio.
Yonghua Capital has a team of 5 people, including 3 partners.
Yonghua Capital's Portfolio
They have invested in a total of 157 companies. Their most recent investment was in Minyue Technology (Series A round) on Apr 16, 2026. Here is the most recent investment by Yonghua Capital:Date | Company | Round | Amount | Co-Investors |
|---|---|---|---|---|
Apr 16, 2026 | Series A | 5361 | - | |
Mar 12, 2026 | Series A | 3766 | ||
Mar 03, 2026 | Series A | 1034 | ||
Feb 05, 2026 | Series D | 2834 |
Here is the portfolio snapshot of Yonghua Capital:
Investments by Year
The maximum number of investments were made in 2018
Team profile of Yonghua Capital
Yonghua Capital has a team of 5 members including 3 Partners and 2 Principals located in China. Yonghua Capital's team does not sit on the board of any company as of now.Here is a list of all team members in Yonghua Capital:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Shanghai | - | ||
Partner | - | - | ||
Partner | Shanghai | - | - | |
Principal | Shanghai | - | ||
Principal | Xuhui | - |
Co-investors of Yonghua Capital
Over the past 32 years, 154 investors have co-invested in Yonghua Capital's portfolio companies.
- Top Co-investors of Yonghua Capital: 154 investors entered a company along with Yonghua Capital. These include investors like Sequoia Capital (3 companies).
Yonghua Capital News
•
Pfizer buys Sunshine Guojian's cancer drug for $1.25B.
Yaorongyun Digital Technology•May 21, 2025•, Orbimed, Yonghua Capital, Jianxin Capital
•
Angitia raises $120M series C to fund trio of musculoskeletal trialsFierce Biotech•Dec 11, 2024•Angitia, Janus Henderson Investors, Orbimed, 3H Health Investment and 2 others
•
Angitia Biopharmaceuticals Raises $120M in Series C FundingFinSMEs•Dec 11, 2024•Angitia, Bain Capital Life Sciences, Janus Henderson Investors, Orbimed and 4 others
•
Atlas doubles down on ‘disciplined’ biotech investing with latest fundraiseBioPharmaDive•Dec 05, 2024•Atlas Venture, Arch Venture Partners, Flagship Pioneering, Bain Capital Life Sciences and 6 others
•
•
•
•
Mellow Energy Completes Pre-A Round FinancingEqualOcean•May 11, 2024•Huajin Capital, Mellow, Yonghua Capital
•
•
